NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.

Autor: Cecchini M; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT, 06510, USA. Michael.cecchini@yale.edu., Cleary JM; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, 02215, USA., Shyr Y; Department of Biostatistics, Vanderbilt University, Nashville, TN, 37203, USA., Chao J; Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA, 91010, USA., Uboha N; Department of Medicine, University of Wisconsin, Madison, WI, 53792, USA., Cho M; Department of Medicine, University of California Irvine, Irvine, CA, 92868, USA., Shields A; Karmanos Cancer Institute, Wayne State University, Detroit, MI, 48201, USA., Pant S; Department of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, Houston, TX, 77030, USA., Goff L; Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, 37203, USA., Spencer K; Department of Medicine, Perlmutter Cancer Center of NYU Langone Health and NYU Grossman School of Medicine, New York, NY, 10016, USA., Kim E; Department of Internal Medicine, University of California Davis, Davis, CA, 95817, USA., Stein S; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT, 06510, USA., Kortmansky JS; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT, 06510, USA., Canosa S; Department of Pathology, Yale University School of Medicine, New Haven, CT, 06510, USA., Sklar J; Department of Pathology, Yale University School of Medicine, New Haven, CT, 06510, USA., Swisher EM; Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, 98195, USA., Radke M; Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, 98195, USA., Ivy P; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, 20892, USA., Boerner S; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT, 06510, USA., Durecki DE; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT, 06510, USA., Hsu CY; Department of Biostatistics, Vanderbilt University, Nashville, TN, 37203, USA., LoRusso P; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT, 06510, USA., Lacy J; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT, 06510, USA.

Publikováno v: British journal of cancer [Br J Cancer] 2024 Feb; Vol. 130 (3), pp. 476-482. Date of Electronic Publication: 2023 Dec 22.

Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma.

Autor: Dytfeld D; University of Chicago, Chicago, IL, USA University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA Karol Marcinkowski University of Medical Sciences, Poznan, Poland., Jasielec J; University of Chicago, Chicago, IL, USA., Griffith KA; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA., Lebovic D; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA., Vesole DH; The John Theurer Cancer Center at Hackensack UMC, Hackensack, NJ, USA., Jagannath S; Mount Sinai Medical Center, New York, NY, USA., Al-Zoubi A; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA., Anderson T; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA., Detweiler-Short K; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA., Stockerl-Goldstein K; Washington University School of Medicine, St. Louis, MO, USA., Ahmed A; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA., Jobkar T; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA., Durecki DE; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA., McDonnell K; University of Chicago, Chicago, IL, USA., Mietzel M; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA., Couriel D; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA., Kaminski M; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA., Vij R; Washington University School of Medicine, St. Louis, MO, USA., Jakubowiak AJ; University of Chicago, Chicago, IL, USA University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA ajakubowiak@medicine.bsd.uchicago.edu.

Publikováno v: Haematologica [Haematologica] 2014 Sep; Vol. 99 (9), pp. e162-4. Date of Electronic Publication: 2014 Jun 27.